HOME - Companies - News
 
 
09 March 2021

Compass Labs offer a test for HPV

Author: Katherine Pfaff


Compass Laboratory Services has developed an oral rinse to detect high-risk HPV in the oral cavity, OraGen HPV. The human papillomavirus (HPV) is linked to neck and head cancers. More than 25 million Americans are thought to have HPV. Specific subtypes of HPV are thought to increase cancer risk, making detection important.


OraGen HPV genotyping test is intended to detect strains of high-risk HPV. The test can detect HPV 16/18, which is thought to pose the greatest risk for developing head and neck cancer.

For info contact:
Compass Lab Services
Phone: 901.348.5774
Email: info@compasslabservices.com

Source: www.compasslabservices.com

Related articles

SimplyTest has launched a groundbreaking saliva-based test to detect high-risk strains of oral human papillomavirus (HPV), a major cause of oropharyngeal cancers.


Read more

New solution from Valkyrie BioScience delivers chairside Tomosynthesis and Intelligent Imaging to bridge the gap between 2D and CBCT.


Premier to broaden clinician access to Forward Science’s FDA-cleared, non-drug oral wound dressing for post-procedural periodontal care


Recognition reflects more than three decades of sustained growth for the integrated healthcare support organization


Achievement and service take center stage as the University of Colorado Anschutz School of Dental Medicine honors the Doctor of Dental Surgery (DDS) Class of 2026.


This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate...


 
 
 
 

 
 
 
 

Most popular

 
 

Events